Production (Stage)
NRx Pharmaceuticals, Inc.
NRXP
$3.27
$0.3311.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 284.48% | -12.33% | -13.28% | 43.90% | -71.29% |
| Total Receivables | -- | -- | 0.00% | 0.00% | 0.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -64.93% | 80.20% | -25.16% | 100.37% | -24.15% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -15.90% | -2.83% | 2.17% | -12.72% | 9.18% |
| Total Current Assets | 119.75% | -19.58% | -15.86% | 45.80% | -51.38% |
|
|
|||||
| Total Current Assets | 119.75% | -19.58% | -15.86% | 45.80% | -51.38% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -4.30% | -1.97% | -7.29% | -12.93% | 2.32% |
| Total Assets | 107.89% | -18.18% | -15.24% | 38.97% | -48.22% |
|
|
|||||
| Total Accounts Payable | 4.38% | -15.13% | -2.97% | -19.95% | 35.25% |
| Total Accrued Expenses | -67.75% | 194.50% | -19.41% | 23.64% | 10.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 573.92% | -59.15% | -60.14% | 12.86% | -26.00% |
| Total Finance Division Other Current Liabilities | -8.92% | 141.70% | 72.59% | 14,646.15% | 52.94% |
| Total Other Current Liabilities | -8.92% | 141.70% | 72.59% | 14,646.15% | 52.94% |
| Total Current Liabilities | 49.80% | 7.70% | -14.19% | 25.44% | -1.00% |
|
|
|||||
| Total Current Liabilities | 49.80% | 7.70% | -14.19% | 25.44% | -1.00% |
| Long-Term Debt | -- | 67.87% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 21.87% | 15.42% | -1.57% | 25.44% | -1.00% |
|
|
|||||
| Common Stock & APIC | 1.40% | 1.87% | 0.48% | 1.87% | 1.32% |
| Retained Earnings | -1.98% | -3.37% | -0.61% | -3.04% | -2.58% |
| Treasury Stock & Other | -- | -- | -- | 0.00% | 0.00% |
| Total Common Equity | -8.35% | -23.38% | -2.34% | -22.05% | -28.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.35% | -23.38% | -2.34% | -22.05% | -28.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.35% | -23.38% | -2.34% | -22.05% | -28.43% |
|
|
|||||